Neutrophils are the first immune cells to kill invading microbes at sites of infection using a variety of processes, including the release of proteases, phagocytosis and the production of neutrophil extracellular traps (NETs). NET formation, or NETosis, is a specific and highly efficient process, which is induced by a variety of stimuli leading to expulsion of DNA, proteases and antimicrobial peptides to the extracellular space. However, uncontrolled NETosis may lead to adverse effects and exert tissue damage in pathological conditions. Here, we show that the ATP channel pannexin1 (Panx1) is functionally expressed by bone marrow-derived neutrophils (BMDNs) of wild-type (WT) mice and that ATP contributes to NETosis induced in vitro by the calcium ionophore A23187 or phorbol 12-myristate 13-acetate (PMA). Interestingly, neutrophils isolated from Panx1 −/− mice showed reduced and/or delayed induction of NETosis. Brilliant blue FCF dye (BB-FCF), a Panx1 channel inhibitor, decreased NETosis in wild-type neutrophils to the extent observed in Panx1 −/− neutrophils. Thus, we demonstrate that ATP and Panx1 channels contribute to NETosis and may represent a therapeutic target.
lupus erythematosus 3, 5 . Thus, there is a need to identify NET inhibitors and new therapeutic targets to prevent worsening conditions in NETs-related diseases.
Accumulating evidence shows that innate immune responses are associated with extracellular nucleotides, particularly adenosine 5′-triphosphate (ATP). ATP acts as an extracellular signalling molecule that can modulate cellular processes through activation of specific cell membrane purinergic receptors. Under inflammatory conditions, ATP is present in the extracellular space due to its release from the cell cytoplasm. Among other mechanisms, pannexin-made membrane channel might be essential for inside out signalling by releasing ATP to the extracellular space 16 . Pannexin (Panx) family consists of three isoforms (Panx1, Panx2 and Panx3), Panx1 being ubiquitously expressed 17, 18 . Neutrophils were found to release ATP through Panx1 channels, which in turn activates purinergic receptors in a paracrine manner 19, 20 . In this study, we questioned whether ATP and Panx1 contributed to NETosis using wild-type (WT) and Panx1 −/− murine neutrophils activated with the calcium ionophore A23187 or PMA. We report here that extracellular ATP amplifies NETosis through purinergic stimulation. We also show that NETosis is reduced in Panx1 −/− neutrophils and that pharmacological inhibition of Panx1 slowed NETosis triggered by A23187 and PMA.
Results
NET formation induced by A23187 and PMA. A23187 and PMA are commonly used to trigger vital (NADPH-independent) and suicidal (NADPH-dependent) NETosis. Formation of NET was first verified by immunostaining of citrullinated histones in WT bone marrow derived neutrophils (BMDNs) exposed to A23187 or PMA for 2 h or untreated. As illustrated in Fig. 1A and Supplemental Fig. 1 , histone citrullination was stronger in A23187 stimulated neutrophils when compared to PMA stimulated cells, which is consistent with the fast and robust response evoked by the calcium ionophore 21 .
NET formation can also be monitored as a function of time by using the cell impermeable SYTOX green dye, which binds to extracellular DNA. An example of NET formation by time-lapse imaging in a global population of stimulated BMDNs is shown in Video 1 (Supplemental Video 1). To provide quantitative and temporal analysis of NETosis, SYTOX green dye fluorescence over time was quantified using a plate reader. Typically, increase in SYTOX green fluorescence followed a sigmoidal curve; A23187 induced rapid and robust extracellular DNA release, reaching a plateau within 3-4 h ( Extracellular ATP contributes to NETosis. To evaluate the contribution of ATP and purinergic signalling to NETosis, neutrophils were stimulated with A23187 or PMA in the presence of drugs that would reduce ATP degradation, such as an inhibitor of the surface ecto-enzyme CD39 (ARL67156), or drugs that would inhibit activation of purinergic receptors. As shown in Fig. 2A ,B, PMA-induced, but not A23187-induced, NETosis was enhanced in the presence of ARL67156. NADPH-independent NETosis may not be enhanced by ARL67156 due to the already maximal effect caused by the calcium ionophore. In agreement, we found that a P2Y 2 receptor antagonist (AR-C 118925XX) decreased NET formation induced by A23187 and PMA (Fig. 2C,D) . These results were corroborated by treating cells with apyrase, an ATP scavenger, which decreased NETosis triggered by A23187 or PMA ( Fig. 2E,F) . Thus, extracellular ATP may act in an autocrine and/or paracrine manner on purinergic signalling to modulate NETosis.
We next investigated whether ATP alone triggered NETosis. However, neither 50 μM nor 500 μM of extracellular ATP enhanced SYTOX fluorescence above that of controls ( Fig. 3A,B ). In addition, combining ATP and A23187 did not modify the time course or the amplitude of NETosis induced by A23187 alone (Fig. 3C ,D), confirming that NETosis induced by the calcium ionophore was already maximal. Interestingly, we observed that adding ATP to PMA stimulation markedly enhanced NETosis, following a faster and more pronounced S-shaped kinetic similar to that observed for A23187 stimulation (Fig. 3E,F) . Together, the data suggest that extracellular ATP is a modulator of NETosis, the rate and amplitude of which depend of the triggers used and of the purinergic signalling activated.
Panx1 is functionally expressed in neutrophils. Panx1, which forms ATP channels in neutrophils 19, 20 , could contribute to ATP release during NETosis. Immunostaining of BMDNs confirmed Panx1 protein expression; Panx1 was mostly detected at the neutrophil membrane ( Fig. 4A and Supplemental Fig. 2A ). In contrast, Panx1 protein were absent in neutrophils isolated from Panx1 −/− mice (Fig. 4A ). This was also confirmed at the mRNA ( Fig. 4B ) and at the protein (Supplemental Fig. 2B ) levels. To exclude compensatory upregulation of other pannexin family members in Panx1 −/− BMDNs 22 , we verified for Panx2 and Panx3 transcripts, which were not detected in both WT and Panx1 −/− BMDNs (Fig. 4B ). Connexin43 (Cx43) transcripts levels were very low and similar in both genotypes ( Fig. 4B ), excluding secondary effects from Cx43, which has been shown to form ATP releasing hemichannels in various cell types 20, 23 . Panx1 function was first evaluated in WT and Panx1 −/− BMDNs by measurement of ATP release using hypo-osmotic shock (Fig. 4C ). Within 5 min after stimulation, there was a marked increase in ATP release in WT neutrophils compared to Panx1 −/− neutrophils. Interestingly, A23187 or PMA stimulations did not elicit ATP release (Fig. 4C ).
YO-PRO-1 dye uptake is another approach to monitor Panx1 function. Global measurement of YO-PRO-1 dye uptake in the overall neutrophil population was detected using a plate reader ( Fig. 4D ). BMDNs were first superfused with a control solution to acquire baseline fluorescence and YO-PRO-1 dye was then added to the medium. As a trigger to maximally open Panx1 channels, neutrophils were subsequently superfused by a hypotonic solution containing the same concentration of YO-PRO-1 dye. Increases in fluorescent signal were observed, the YO-PRO-1 fluorescence being markedly enhanced in WT as compared to Panx1 −/− neutrophils ( Fig. 4D ; black vs. grey curves). Importantly, YO-PRO-1 uptake in WT neutrophils decreased back to the level observed for Panx1 −/− BMDNs in the presence of the Panx1 inhibitors BB-FCF or spironolactone ( Fig. 4D ; black vs. blue and red curves, respectively). Quantification of the overall neutrophil population confirmed the reduction of YO-PRO-1 uptake in Panx1 −/− neutrophils and in the presence of Panx1 inhibitors (Fig. 4E ). These results indicate that Panx1 is functionally expressed in BMDNs.
NETosis is delayed in Panx1 −/− neutrophils and by Panx1 channel inhibition. To determine if
Panx1 channels contribute to NETosis, we compared the kinetics of extracellular DNA detection between WT and Panx1 −/− BMDNs exposed to A23187 ( Although no difference was observed for the Hill slope parameters, Max was decreased in Panx1 −/− neutrophils exposed to A23187, while ET 50 was increased in Panx1 −/− neutrophils exposed to PMA. These results indicate that Panx1 contributes to NET formation and modulates the kinetic of NETosis according to the trigger used.
BB-FCF has been shown to inhibit Panx1 channels in various cell types 24, 25 , including neutrophils ( Fig. 4D,E) . Therefore, we evaluated the ability of the inhibitor to modulate the kinetic of NETosis in response to A23187 and PMA. We observed a delay in the kinetics in BB-FCF-treated WT neutrophils, which was comparable to the behaviour of Panx1 −/− BMDNs (Fig. 6A ,C). After 6 h, comparison of the SYTOX fluorescence measurements showed significant reduction WT neutrophils exposed to BB-FCF ( Fig. 6B ). We observed similar effects in BB-FCF-treated WT neutrophils with PMA stimulation (Fig. 6D) . These results show that Panx1 inhibitor BB-FCF reduced NETosis in WT BMDNs stimulated with both A23187 and PMA.
Discussion
This study provides evidence that Panx1 and extracellular ATP, which is often elevated during inflammation, contribute to NETosis. Since the discovery of NETs 2 , NETosis is considered as a causal factor in the severity of various diseases. Whereas several intracellular signalling cascades have been identified, NETosis is clearly distinct from other processes causing cell death like apoptosis, necrosis and necroptosis 12 . Importantly, the initial phase of the process is associated with morphological changes and modifications of histones that prime the neutrophils for later mechanical changes. At this point, chromatin swelling is engaged leading to the irreversible rupture of the nuclear envelope and then the plasma cell membrane 13 . www.nature.com/scientificreports www.nature.com/scientificreports/ A23187 and PMA are commonly used inducers of suicidal and vital NETosis. We confirmed the different dependence of these stimuli to NADPH oxidase and in the level of histone citrullination 5, 21 . As expected, after several hours, both stimuli induced the release of DNA to the extracellular space that could be monitored by the use of the cell impermeable dye SYTOX green. The increase in SYTOX green fluorescence measured on a global www.nature.com/scientificreports www.nature.com/scientificreports/ population of stimulated BMDNs followed a sigmoidal curve. Consistent with video-microscopy recordings, the sigmoidal curve resulted from an increasing number of neutrophils undergoing NETosis with time. Panx1 −/− neutrophils were less sensitive to both A23187-and PMA-induced NETosis, yet different characteristics were www.nature.com/scientificreports www.nature.com/scientificreports/ observed. The number of Panx1 −/− BMDNs undergoing fast DNA release was reduced in response to A23187. However, DNA release was occurring with slower kinetics in Panx1 −/− than in WT neutrophils in response to PMA. Our data also shows decreased ATP release in Panx1 −/− neutrophils. Together, the results indicate that Panx1 accelerates the stimuli-triggered initial phase that leads to chromatin swelling, possibly by releasing ATP to the extracellular environment.
Purinergic regulation of neutrophil function is well established 19, 20 . Extracellular ATP and its hydrolysed derivatives (ADP, AMP and adenosine) are critical signal transduction molecules, the balance of which is regulated by surface ectoenzymes. Thus, ATP and ADP are converted to AMP by ecto-apyrase CD39, which is highly expressed in neutrophils 26 . These nucleotides and nucleosides are ligands to P2 and P1 receptors respectively, which convert extracellular purine concentration into intracellular signals that modulate neutrophil immune response. Interestingly, one study reported that P1 receptor signalling could decrease NETosis induced by Klebsiella pneumonia 27 . The actual concentration of ATP close to the BMDN cell surface, which will vary with time, activity of ectoenzymes and number of activated purinergic receptors, is unknown. Nonetheless, we found that blocking P2Y 2 receptors or scavenging ATP decreased NET formation, pointing to the P2 receptors as a major amplifier of NETosis. Extracellular ATP alone was not able to trigger NETosis, but enhanced NET formation evoked by PMA with kinetics similar to that obtained with A23187 stimulation. P2Y 2 signalling has been previously involved in NET formation during acute phase of cattle neosporosis 28 . Also in line with these data is the report that uridine diphosphate (UDP), which is the natural ligand to P2Y 6 receptor, fails to initiate NET formation in human neutrophils but UDP-mediated P2Y 6 signalling is involved in the monosodium urate crystal-induced formation of NETs 29 . Together, these observations suggests that elevation of intracellular calcium concentration secondary to purinergic receptor activation plays a pivotal role in regulating the velocity of the NET response 21 .
Several mechanisms for ATP release from various cell types have been proposed, including vesicle exocytosis and channel-dependent transport among which connexons (made of connexins) and pannexons (made of pannexins) are extensively studied 30 . The release of ATP through Cx43-made connexons and Panx1 channels was previously reported in neutrophils in response to N-formylmethionyl-leucyl-phenylalanine, lipopolysaccharide or hypertonic saline 31, 32 . Although Panx1 mRNA was detected in WT neutrophils, the levels of Panx2, Panx3 and Cx43 mRNA were negligible in both WT and Panx1 −/− BMDNs, excluding them from a possible compensatory mechanism. The molecular mechanism that opens Panx1 channels in neutrophils exposed to A23187 or PMA have not been examined here. It is worth noting that many cellular changes induced by A23187 and PMA during NETosis, including rise in intracellular calcium and cell swelling 13, 21 , are also known triggers of Panx1 channel opening 33, 34 . Thus, we propose that reduced ATP released by Panx1 −/− BMDNs may lower the ability of the nucleotide and its metabolites to activate purinergic receptors, thus increasing the delay before the point of no return. Once this point is reached and NETosis occurs in some BMDNs, ATP will be released due to membrane rupture, thus accelerating NETosis in the surrounding neutrophils by activating the purinergic signalling cascade. Importantly, we show here that pharmacological inhibition of Panx1 channels with BB-FCF is sufficient to decrease the number of neutrophils undergoing NETosis in response to A23187 and PMA.
The identification of the molecular pathways that contribute to chromatin swelling are relevant to identify therapeutic targets. BB-FCF is an FDA-approved blue dye used for food colouring and, possibly in combination with other purinergic receptor inhibitors, could represent an efficient mean to reduce detrimental NETosis, particularly under excessive inflammatory conditions. This is not only of relevance for (auto-) inflammatory diseases but also for cancer as NETs induced by inflammation could promote the awakening of dormant cancer cells 35 . Future work on animal models whereby Panx1 is selectively deleted from neutrophils will shed some light on the rational of targeting this channel in inflamed tissues.
Materials and Methods
Mice. The Swiss Federal veterinary authorities ("Autorité Cantonale, Direction Générale de la Santé") approved all animal experimentation in accordance to established guidelines and regulations. NETosis experiments were performed using WT and Panx1 −/− mice on a C57BL/6 background. Panx1 −/− mice were previously characterised 36 . All experiments were performed using sex and age-matched animals. Mice were bred in the in-house animal facility and kept under standard housing conditions with fixed light/dark cycle. Immunofluorescence. 10 5 BMDNs were seeded on coverslips by centrifugation in 24-well plate and were fixed with paraformaldehyde (4%) for 20 min at room temperature. Next, permeabilisation was performed with Triton-X100 (0.3%), neutralisation with ammonium chloride (0.5 M), and blocking with PBS containing bovine serum albumin (BSA; 2%). The chicken anti-mouse Panx1 (1:500), recognizing amino acids 414-425 38 , citrullinated histone 3 (1:300, Abcam, AB5103) and neutrophil marker NIMP-R14 (1/250, Santa Cruz, sc-59338) primary antibodies were then applied overnight. Goat anti-chicken (1:500) DyLight488 antibody (Jackson Laboratories), goat anti-rabbit (1:2000) Alexa 488 (Thermofisher Scientific) and IgG anti-rat (1:100) rhodamine secondary antibodies were then applied for 2 h at room temperature (RT) with DAPI counterstaining. Samples were mounted on coverslips with Vectashield (Vector Laboratories, #H-1000). Images were acquired using inverted Zeiss LSM700 laser-scanning confocal microscope (Carl Zeiss) through 10x, 20x, 40x or 63x oil immersion objectives. Quantification was performed using Fiji software. Histone H3 citrullination and DAPI fluorescence were quantified as area per image, while Panx1 fluorescence was quantified as integrated density per region of interest (ROI) in WT and Panx1 −/− BMDNs. Ratio values were expressed as arbitrary unit.
Western blot. BMDNs and splenocytes from WT and Panx1 −/− mice were incubated in RIPA lysis buffer (1 mM PMSF, 0.2% Na-deoxycholate, 2 mM Na-orthovanadate, 10 mM NaF, 1X Roche Protease Inhibitor, 0.05% SDS, 1X NP40, 1 mM EDTA, pH 7.4.) for 15 minutes on ice. Samples were then centrifuged at 10'000 g and 4 °C for 15 minutes. Proteins were quantified by Pierce bicinchoninic acid (BCA) assay (ThermoFisher Scientific). 50 µg and 10 µg of total protein from BMDNs and splenocytes, respectively, were separated on a sodium dodecyl sulphate (SDS) polyacrylamide gel and transferred on nitrocellulose membrane. Membrane was blocked in PBS-Tween (0.01%-PBST) buffer containing 5% defatted milk for 1 hour at RT with agitation. Monoclonal Panx1 (D9M1C Cell Signalling, 91137) antibodies were diluted 1: 1000 in 5% milk in PBST for overnight incubation at 4 °C, followed by 2 hours incubation at RT with goat anti-rabbit horse radish peroxidase (HRP)-conjugated antibody (Jackson ImmunoResearch Laboratories). Revelation was performed using WesternBright ™ Sirius ™ (Advansta). Total amount of loaded protein was verified using Ponceau red staining. Panx1 functional assay. For ATP release assay, BMDNs were left to equilibrate in Tyrode's buffer (124 mM NaCl, 2.4 mM KCl, 10.8 mM NaHCO 3 , 0.4 mM NaH 2 PO 4 *H 2 O, 0.9 mM MgCl 2 *6H 2 O, 1.8 mM CaCl 2 *6H 2 O, pH 7.35). Panx1 channel mediated ATP release was activated by reducing osmolarity of the Tyrode's buffer by decreasing NaCl to 30.24 mM. WT and Panx1 −/− BMDNs were stimulated with appropriate controls for 5 min. Cells were centrifuged at 1200 rpm for 5 minutes and supernatants were collected for ATP measurement using the ATP bioluminescent assay kit (#FLAA, Sigma Aldrich), according to the manufacturer's instructions.
For dye uptake assay, BMDNs were seeded in 384-well plate and maintained in a physiological solution (136 mM NaCl, 4 mM KCl, 1 mM CaCl 2 , 1 mM MgCl 2 , and 2.5 mM glucose, buffered to pH 7.4 with 10 mM HEPES-NaOH solution). YO-PRO-1 Iodide (5 µM, ThermoFisher Scientific, #Y3603) was added to equilibrate cells. Hypo-osmotic shock was induced to maximally open Panx1 channels. Inhibitors of Panx1 BB-FCF dye-Erioglaucine disodium salt (Sigma Aldrich, #80717) 24, 25 and spironolactone (Sigma Aldrich, #S3378) 39 were prepared in DMSO and used at 1μM and 100 μM, respectively. Global quantification of YO-PRO-1 dye uptake per well was performed using the FDSS/µCELL Functional Drug Screening System (Hamamatsu Photonics).
In Vitro quantification of NET formation. NETosis measurements were made as follows; 10 5 BMDNs were seeded in 96-well assay plate (Corning #3603, Sigma Aldrich). 50 nM PMA or 1 μM A23187 (Sigma Aldrich, #P1585, #C7522 respectively) were added to wells in duplicates/triplicates with DMSO control included. The cell impermeable SYTOX green nucleic acid stain (5 µM, ThermoFisher Scientific #S7020) was added. SYTOX green stain measurement was performed using Spark Microplate Reader (Tecan) fitted with monochromatic filter 504/523 nm. 1 μM BB-FCF was used for Panx1 inhibition with appropriate controls. ATP scavenger apyrase grade VII (50 U/ml, Sigma Aldrich, #A6535), P2Y 2 receptor antagonist AR-C 118925XX (500 nM, Tocris, #4890) and CD39 ARL 67156 trisodium salt (100 μM, Tocris, #1283) were used for the purinergic signalling experiments involving ATP release. 10 mM N-acetyl cysteine (NAC, Sigma Aldrich #A0737) was used for ROS inhibition. For time-lapse imaging, SYTOX green dye (5 μM) was added to BMDNs seeded in 96-well assay plate. Cells were stimulated with 1 μM A23187 for 30 min in the presence of appropriate controls. Images were acquired at
